Chemical Biology & Drug Design

Wiley

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Chemical Biology & Drug Design is a journal published by Wiley in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,550 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Wiley
ISSN
1747-0277 · 1747-0285
Country
United Kingdom
Access
Not open access / not declared
Declared publication charge
3,550 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2006-01-01
  • PUBMED · 2010-09-01
Indexing
MEDLINE · PUBMED
APC
3,550 USD
Declared review time (DOAJ)
—
Actual review time (measured)
101 days received→accepted — computed from PubMed (n=98)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

4223

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

97

i10-index

2028

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
87%
ORCID iDs in current deposits
64%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
Chemical biology and drug design
Source type
journal
NLM unique ID (PubMed)
101262549
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Synthesis and biological activity
  • Synthesis and biological activity
  • Chemical Synthesis and Analysis
  • Chemical Synthesis and Analysis
  • Synthesis and Biological Evaluation
  • Synthesis and Biological Evaluation
Show all subjects (50)
  • Click Chemistry and Applications
  • Click Chemistry and Applications
  • Cancer therapeutics and mechanisms
  • Cancer therapeutics and mechanisms
  • Cholinesterase and Neurodegenerative Diseases
  • Cholinesterase and Neurodegenerative Diseases
  • Bioactive Compounds and Antitumor Agents
  • Bioactive Compounds and Antitumor Agents
  • HIV/AIDS drug development and treatment
  • HIV/AIDS drug development and treatment
  • Receptor Mechanisms and Signaling
  • Receptor Mechanisms and Signaling
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Quinazolinone synthesis and applications
  • Antimicrobial Peptides and Activities
  • Antimicrobial Peptides and Activities
  • Quinazolinone synthesis and applications
  • Peptidase Inhibition and Analysis
  • Peptidase Inhibition and Analysis
  • Protein Structure and Dynamics
  • Protein Structure and Dynamics
  • Biochemical and Structural Characterization
  • Biochemical and Structural Characterization
  • Biochemical and Molecular Research
  • Biochemical and Molecular Research
  • RNA Interference and Gene Delivery
  • Diverse Scientific and Economic Studies
  • RNA Interference and Gene Delivery
  • Diverse Scientific and Economic Studies
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
  • Neuropeptides and Animal Physiology
  • Neuropeptides and Animal Physiology
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Synthesis and Characterization of Heterocyclic Compounds
  • Synthesis and Characterization of Heterocyclic Compounds
  • HIV Research and Treatment
  • HIV Research and Treatment
  • Research on Leishmaniasis Studies
  • Microbial Natural Products and Biosynthesis

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: